» Articles » PMID: 22850167

Prevalence of Anal Incontinence Among Norwegian Women: a Cross-sectional Study

Overview
Journal BMJ Open
Specialty General Medicine
Date 2012 Aug 2
PMID 22850167
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Anal incontinence (AI) is a symptom associated with age, bowel symptoms and obstetric injuries. Primary aim of the study was to establish the prevalence of AI among women and secondarily to evaluate the impact on daily life and conditions associated with AI.

Design: A cross-sectional study.

Setting: Participants attended research stations located in different parts of Nord-Trøndelag county, Norway. Data were collected through interviews, questionnaires and clinical examinations.

Participants: In total, 40 955 community-dwelling women aged 30 years and older were invited. A total of 25 037 women participated, giving a participation rate of 61.1%.

Primary And Secondary Outcome Measures: Fecal incontinence and flatal incontinence was defined as involuntary loss of feces and flatus weekly or more, respectively. AI was defined as the involuntary loss of feces and/or flatus weekly or more. Urgency was defined as the inability to defer defecation for 15 min. Statistical methods included prevalence estimates and logistic regression analysis.

Results: Questions about AI were completed by 20 391 (82.4%) women. Among the 20 391 women, AI was reported by 19.1% (95% CI 18.6% to 19.7%) and fecal incontinence was reported by 3.0% (95% CI 2.8% to 3.2%). Urgency was experienced by 2586 women (12.7%, 95% CI 12.2 to 13.1). Impact on daily life was stated by 794 (26.0%, 95% CI 24.4 to 27.5) women with AI. In bivariate age-adjusted analysis of AI, OR and CI for urgency (OR 3.19, 95% CI 2.92 to 3.49) and diarrhoea (OR 3.81, 95% CI 3.32 to 4.38) revealed strongest associations with AI.

Conclusions: AI affects one in five women older than 30 years. Strongest associated symptoms are urgency and diarrhoea.

Trial Registration Number: The study was approved by the Regional Committee for Medical and Health Research Ethics (No. 2009/1214) and followed the Declaration of Helsinki.

Citing Articles

Pelvic floor disorders and impact on sexual function: a cross-sectional study among non-sexually active and sexually active women.

Stafne S, Ulven S, Prosch-Bilden T, Saga S Sex Med. 2024; 12(2):qfae024.

PMID: 38725639 PMC: 11079667. DOI: 10.1093/sexmed/qfae024.


Global Prevalence of Fecal Incontinence in Community-Dwelling Adults: A Systematic Review and Meta-analysis.

Mack I, Hahn H, Godel C, Enck P, Bharucha A Clin Gastroenterol Hepatol. 2023; 22(4):712-731.e8.

PMID: 37734583 PMC: 10948379. DOI: 10.1016/j.cgh.2023.09.004.


Symptoms of anal incontinence and quality of life: a psychometric study of the Norwegian version of the ICIQ-B amongst hospital outpatients.

Saga S, Vinsnes A, Norton C, Haugan G Arch Public Health. 2022; 80(1):251.

PMID: 36494843 PMC: 9733285. DOI: 10.1186/s13690-022-01004-z.


Prevalence of pelvic floor dysfunction in women in Riyadh, Kingdom of Saudi Arabia: A cross-sectional study.

Malaekah H, Al Medbel H, Al Mowallad S, Al Asiri Z, Albadrani A, Abdullah H Womens Health (Lond). 2022; 18:17455065211072252.

PMID: 35100887 PMC: 8811438. DOI: 10.1177/17455065211072252.


Epidemiologic Trends and Diagnostic Evaluation of Fecal Incontinence.

Sharma A, Rao S Gastroenterol Hepatol (N Y). 2021; 16(6):302-309.

PMID: 34035733 PMC: 8132710.


References
1.
Nichols C, Ramakrishnan V, Gill E, Hurt W . Anal incontinence in women with and those without pelvic floor disorders. Obstet Gynecol. 2005; 106(6):1266-71. DOI: 10.1097/01.AOG.0000187303.43011.12. View

2.
Bohle B, Belvis F, Vial M, Maestre Y, Pera M, Castillo M . Menopause and obstetric history as risk factors for fecal incontinence in women. Dis Colon Rectum. 2011; 54(8):975-81. DOI: 10.1097/DCR.0b013e31821c404a. View

3.
Ebbesen M, Hannestad Y, Midthjell K, Hunskaar S . Diabetes related risk factors did not explain the increased risk for urinary incontinence among women with diabetes. The Norwegian HUNT/EPINCONT study. BMC Urol. 2009; 9:11. PMC: 2753577. DOI: 10.1186/1471-2490-9-11. View

4.
Whitehead W, Borrud L, Goode P, Meikle S, Mueller E, Tuteja A . Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology. 2009; 137(2):512-7, 517.e1-2. PMC: 2748224. DOI: 10.1053/j.gastro.2009.04.054. View

5.
Madoff R, Parker S, Varma M, Lowry A . Faecal incontinence in adults. Lancet. 2004; 364(9434):621-32. DOI: 10.1016/S0140-6736(04)16856-6. View